MedPath

Three-armed study for therapy of primary and secondary syphilis in HIV infectio

Phase 4
Conditions
A53.9
Syphilis, unspecified
Registration Number
DRKS00000389
Lead Sponsor
St. Josef HospitalInterdisziplinäre Immunologische Ambulanz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
115
Inclusion Criteria

HIV positive Patients with serologically proven early syphilis

Exclusion Criteria

-known sensibilization agaist ß-lactam antibiotics
-patients that were treated within the last 48h with an agent that is active against treponema pallidum
-pregnant or lactating women
-patients with late syphilis (latent syphilis of unknown duration, tertiary syphilis or neuro syphilis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
treatment failure defined as:<br>-retreatment or<br>-treatment with any antibiotic active against treponema pallidum or<br>-no reduction by 2 titer levels in VDRL or FTAabs19S IgM after 48 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath